Cytokinetics (CYTK) is a clinical stage biotechnology company that focuses on the discovery and development of novel molecular therapeutics in relation to muscle function.
Although back pain is common, it can be difficult for physicians to determine the exact cause of the pain using current testing methods.
Promising data from a Phase I clinical trial of CK-2017357 was announced in January.
A roundup of news from the Heart Failure Society of America’s annual meeting.
Copyright © 2025 | WordPress Theme by MH Themes